ArticleFrontiers in public health2025
Piloting a cancer awareness app across six European countries: a pre-post study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Measuring eHealth Literacy in the European Economic Area, Switzerland, and the United Kingdom: Scoping Review.Journal of medical Internet research · 2026Article
- Assessing the User Experience of the EU Mobile App for Cancer Prevention: Mixed Methods Study.JMIR formative research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Background: Cancer remains a significant public health challenge in Europe, accounting for over 22% of global cancer cases. Mobile health applications may help to increase the awareness of cancer risks and preventive behaviors. However, usability barriers and disparities in digital health literacy (DHL) may limit their impact. Objective: This study evaluated the usability of the EU Mobile App for Cancer Prevention and changes in cancer awareness associated with use across six European countries (Cyprus, Germany, Hungary, Portugal, Slovenia, Spain), focusing on variations by DHL and sociodemographic factors. Methods: A pre-post design was employed, combining pre- and post-usage surveys (N = 328 pre; n = 77 post). Participants interacted with the app for 7 days. Usability was assessed via the System Usability Scale (SUS), cancer awareness via an 18-item quiz, and DHL using the eHEALS tool. Descriptive statistics summarized key variables, while t-tests and ANOVAs assessed group differences in usability and cancer awareness outcomes. Results: A total of 328 participants completed the pre-usage survey, with 77 proceeding to the post-usage phase; the primary reason for dropout was technical difficulties. The app's overall usability was rated as moderate (Mean = 62.56 on the SUS) and did not differ significantly across demographic or usage subgroups. Cancer awareness scores improved from 50.45 to 53.31 ( Conclusion: This pilot study demonstrates that the EU Mobile App for Cancer Prevention can enhance cancer awareness, while currently the usability was judged to be moderate. Targeted refinements in navigation, setup procedures, and content tailoring for low-DHL users are essential to improve engagement and ensure equitable reach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.